Heart transplantation
1 paper
Trial sponsors
Company7 trialsPhase 41,202 people
Novartis Pharmaceuticals Corporation
Company5 trialsPhase 4632 people
Company4 trialsPhase 4518 people
2 trialsPhase 4134 people
University of Oslo School of Pharmacy
2 trialsPhase 460 people
A.O. Ospedale Papa Giovanni XXIII
1 trialPhase 4200 people
1 trialPhase 440 people
1 trialPhase 2/3111 people
Funding
1 grant since 2018National Institute of Allergy and Infectious DiseasesUS$2.7m
Latest
15 in 12 monthsActas Dermo-sifiliograficas
Immunosenescence markers as predictors of cutaneous keratinocyte carcinoma risk in heart transplant recipients: a prospective pilot study of 30 patients
Cohort study of 30 peopleBiomarkers
bioRxiv
Transplanted hearts assimilate the recipient's biological age
Preprint: experiments in miceMechanisms
European Heart Journal Cardiovascular Imaging
Prospective Systematic Screening for Transthyretin Amyloid Cardiomyopathy in Cardiology Inpatients With Left Ventricular Hypertrophy: the IMPACT Study
Cohort study of 400 peopleCardiomyopathy
Journal of Cardiac Failure
Heart Transplantation in 2076: From Scarcity to Cardiac Restoration
ReviewInterventions
Journal of Cardiac Failure
Heart Transplantation in 2076: Evolution, Transformation, or Obsolescence?
CommentaryInterventions
Journal of Cardiovascular Development and Disease
Discharge AI-ECG-Derived Age and Incidence of Cardiac Allograft Vasculopathy at 3 Years: A Pilot Study
Cohort study of 50 peopleBiomarkers
Nature Cardiovascular Research
Mechanical unloading promotes adult cardiomyocyte proliferation through epicardial NRG1-ERBB4 signaling
Experiments in miceInterventions
bioRxiv
Aging under immunosuppression reshapes human immune compartments and lowers clinical alloreactivity after heart transplantation
Preprint: cohort study of 799 peopleImmune response
Molecular Therapy
T cell senescence induced by DNMT1 deletion mediates cardiac transplant tolerance via altered CDKN1A methylation
Experiments in miceDNA methylation